Apitoria Pharma Private Limited - Company Profile

It is a chemicals and materials private limited company based in Hyderabad, Telangana, India, established in 2017.
2017 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Apitoria Pharma Private Limited

Apitoria Pharma Private Limited, a active private limited company, was established on 20 December 2017 in Hyderabad, Telangana, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: U24298TG2017PTC121342. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹99.00 Cr.

Formerly known as Auro Pharma India Private Limited. It upholds a compliant status. Employing 4,732 professional, Its leadership includes Nityananda Reddy Kambam (Director), Mylandlahalli Rammohan Ashwini (Director), Satakarni Makkapati (Director). Past directors included Venkat Nageswar Chalasani, Nityananda Reddy Kambam, Sapna. It holds ₹1,500.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24298TG2017PTC121342

  • Registration Number

    121342

  • Incorporation Date

    20 December 2017

  • Authorized Capital

    ₹100.00 Cr

  • Paid-Up Capital

    ₹99.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 100.00 Cr
  • Paid Up Capital ₹ 99.00 Cr
  • Company Age 8 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1,500.00 Cr
  • Revenue Growth **** 19.66%
  • Profit Growth **** 32.84%
  • Ebitda **** 19.86%
  • Net Worth 167.15%
  • Total Assets -2.60%
Company report

Apitoria Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Apitoria Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Apitoria Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nityananda Reddy Kambam Director 09 Feb 2023 Current
Mylandlahalli Rammohan Ashwini Director 29 Mar 2024 Current
Satakarni Makkapati Director 23 May 2023 Current
Santhanam Subramanian Director 09 Feb 2023 Current
Santanu Mukherjee Additional Director 31 Jul 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 20 Aug 2023 Past
Pramod Abcsdd Director 10 Jun 2019 Past
Pramod Abcsdd Additional Director 26 Aug 2019 Past
Pramod Abcsdd Additional Director 11 Aug 2024 Past
Pramod Abcsdd Additional Director 20 Aug 2023 Past
Pramod Abcsdd Additional Director 20 Aug 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Apitoria Pharma.

Apitoria Pharma Private Limited, for the financial year ended 2025, experienced significant growth in revenue, with a 19.66% increase. The company also saw a substantial improvement in profitability, with a 32.84% increase in profit. The company's net worth Soared by an impressive increase of 167.15%.

Apitoria Pharma revenue growth over time
Apitoria Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 19.66%
*******
*******
*******
*******
Revenue from Operations
*******
 19.68%
*******
*******
*******
*******
Total Assets
*******
 -2.60%
*******
*******
*******
*******
Profit or Loss
*******
 32.84%
*******
*******
*******
*******
Net Worth
*******
 167.15%
*******
*******
*******
*******
EBITDA
*******
 19.86%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Apitoria Pharma?

In 2024, Apitoria Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹15,000,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 1500.00 Cr
Latest Charge Details
Date Lender Amount Status
30 Oct 2023 State Bank Of India ₹1,500.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Apitoria Pharma?

Apitoria Pharma has a workforce of 4732 employees as of Nov 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Apitoria Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apitoria Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Apitoria Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Apitoria Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    The activity Santanu Mukherjee was appointed as a Additional Director was appointed as a Additional Director on 31 Jul 2025 & has been associated with this company since 6 months 14 days . was completed.

  • Charges

    Progress on A charge with State Bank Of India of Rs. 1,500.00 Cr registered on 30 Oct 2023 with Charge ID 100812350 was modified on 17 Apr 2025. was documented.

  • Balance Sheet

    The activity Apitoria Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Srinivas Bodige was appointed as a Company Secretary was appointed as a Company Secretary on 15 Nov 2024 & has been associated with this company since 1 year 2 months . was documented.

  • Director Appointment

    Progress on Brundaban Dash was appointed as a Cfo was appointed as a Cfo on 19 Apr 2024 & has been associated with this company since 1 year 9 months . was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Apitoria Pharma Private Limited?

The CIN of Apitoria Pharma Private Limited is U24298TG2017PTC121342.

Where is Apitoria Pharma Private Limited headquartered?

Apitoria Pharma Private Limited is headquartered at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.

When was Apitoria Pharma Private Limited incorporated?

Apitoria Pharma Private Limited was incorporated on 20 December 2017.

Who are the current directors of Apitoria Pharma Private Limited?

The current directors of Apitoria Pharma Private Limited are

What is the primary industry of Apitoria Pharma Private Limited?

The primary industry of Apitoria Pharma Private Limited is Manufacturing.

Is Apitoria Pharma Private Limited a listed company?

Apitoria Pharma Private Limited is unlisted.

What is the capital structure of Apitoria Pharma Private Limited?

The authorized capital of Apitoria Pharma Private Limited is ₹100.00 Cr, and the paid-up capital is ₹99.00 Cr.

What is the compliance status of Apitoria Pharma Private Limited?

The compliance status of Apitoria Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available